semaglutide alcohol use disorder study GLP-1 medications: The next big thing in treatment? – Recovery Research Institute Semaglutide for weight loss was

Several situations warrant a conversation with your GP or prescribing clinician

When unopened

With a growing number of patients using these medications for diabetes or to meet certain optimization goals before undergoing hip and knee reconstructive surgery, our aim was to establish evidence-based guidelines on when to discontinue these to enhance patient safety and surgical success. Study Data The study authors used the TriNetX Research Network, a multi-institutional national aggregated database, to identify patients who underwent TKA or THA between January 1, 2018, and January 1, 2023

Nausea affects between 25% and 44% of people taking these medications, making it the most common side effect

Rights and permissions About this article Cite this article Atwal, P., Medina, C., Burrage, L

This collective experience provides valuable guidance beyond marketing materials